OTC · ADXS
Ayala Pharmaceuticals, Inc.
$0.60$0.00 (0.0%)
Ayala Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 24.65% below the high.
Loading market information…
OTC · AAGH · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
America Great Health’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow America Great Health’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating as a U.S.-based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements. The company, which originated as Crown Marketing, adopted the name America Great Health in March 2017. Established in 2013, AAGH's headquarters are located in Alhambra, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.60$0.00 (0.0%)
Ayala Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 24.65% below the high.
CA$0.07-CA$0.01 (-7.14%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 51.85% below the high.
$0.05$0.00 (0.0%)
Agentix Corp.’s quoted price sits in the upper half of its reported 52-week range, 24.29% below the high.
$0.00$0.00 (0.0%)
Health Sciences Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
CA$0.32-CA$0.04 (-9.86%)
Grey Matters Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.44% below the high.
CA$0.01+CA$0.01 (+100.0%)
Appili Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.22$0.00 (0.0%)
SB Technology Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.21% below the high.
$0.00$0.00 (-23.08%)
Regen BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.37% below the high.
